Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI Registry.
Julien HM, Wang Y, Curtis JP, Johnston-Cox H, Eberly LA, Wang GJ, Nathan AS, Fanaroff AC, Khatana SAM, Groeneveld PW, Secemsky EA, Eneanya ND, Vora AN, Kobayashi T, Barbery C Jr, Chery G, Kohi M, Kirksey L, Armstrong EJ, Jaff MR, Giri J. Julien HM, et al. Among authors: secemsky ea. Circ Cardiovasc Interv. 2023 Jun;16(6):e011485. doi: 10.1161/CIRCINTERVENTIONS.121.011485. Epub 2023 Jun 20. Circ Cardiovasc Interv. 2023. PMID: 37339237
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Shah RM, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Secemsky EA, et al. JACC Cardiovasc Interv. 2016 Dec 12;9(23):2376-2386. doi: 10.1016/j.jcin.2016.09.020. Epub 2016 Nov 9. JACC Cardiovasc Interv. 2016. PMID: 27838271 Free article.
Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Steg PG, Massaro JM, Apruzzese PK, Mauri L; Dual Antiplatelet Therapy Study Investigators. Secemsky EA, et al. JACC Cardiovasc Interv. 2017 May 8;10(9):942-954. doi: 10.1016/j.jcin.2017.02.013. JACC Cardiovasc Interv. 2017. PMID: 28473118 Free article. Clinical Trial.
Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin IS, Shah RM, Patel DB, Rao SV, Baklanov DV, Moussa I, Kennedy KF, Secemsky EA, Yeh RW, Kontos MC, Vetrovec GW. Jovin IS, et al. Among authors: secemsky ea. JACC Cardiovasc Interv. 2017 Jun 12;10(11):1102-1111. doi: 10.1016/j.jcin.2017.03.021. Epub 2017 May 17. JACC Cardiovasc Interv. 2017. PMID: 28527778 Free article.
Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.
Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Patel D, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Secemsky EA, et al. Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9):e003741. doi: 10.1161/CIRCOUTCOMES.117.003741. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28855222
Femoropopliteal Stent Implantation.
Secemsky EA, Armstrong EJ. Secemsky EA, et al. Circ Cardiovasc Interv. 2018 Aug;11(8):e007134. doi: 10.1161/CIRCINTERVENTIONS.118.007134. Circ Cardiovasc Interv. 2018. PMID: 30354788 No abstract available.
227 results